Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in MRA Core Studies

NCT00720798 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00720798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00720798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in MRA Core Studies
Lead sponsor
Hoffmann-La Roche
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
April 30, 2013
Enrollment
2,067 (actual)
Sites
295

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis